Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression

International Immunology

Volumn 22, Issue 5, 2010, Pages 359-366

  Ripley, Barry J M ^a,b   Fujimoto, Minoru ^b   Serada, Satoshi ^b   Ohkawara, Tomoharu ^b   Nishikawa, Teppei ^b   Terabe, Fumitaka ^b   Matsukawa, Yuko ^b   Stephanou, Anastasis ^c   Knight, Richard A ^c   Isenberg, David A ^c   Latchman, David S ^c   Kishimoto, Tadamitsu ^a   Naka, Tetsuji ^b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Immunotherapy; LPS signaling; STAT5

Indexed keywords

EPIGALLOCATECHIN GALLATE; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MONOCYTE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TEA;

ANIMALS; ANTIOXIDANTS; CATECHIN; CELLS, CULTURED; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TEA; UP-REGULATION;

EID: 77953988942     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq015     Document Type: Article

References (33)

1. Sayama, K., Oguni, I., Tsubura, A., Tanaka, S. and Matsuzawa, A. 2003. Inhibitory effects of autoimmune disease by green tea in MRL-Faslprcg/Faslprcg mice. In Vivo 17:545.
2. Leong, H., Mathur, P. S. and Greene, G. L. 2008. Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea. Breast Cancer Res. Treat. 107:359.
3. Caporali, A., Davalli, P., Astancolle, S. et al. 2004. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 25:2217.
4. Gillespie, K., Kodani, I., Dickinson, D. P. et al. 2008. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life Sci. 83:581.
5. Stuart, E. C., Scandlyn, M. J. and Rosengren, R. J. 2006. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 79:2329.
6. Menegazzi, M., Tedeschi, E., Dussin, D. et al. 2001. Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J. 15:1309.
7. Youn, H. S., Lee, J. Y., Saitoh, S. I. et al. 2006. Suppression of MyD88- and TRIF-dependent signaling pathways of toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 72:850.
8. Sah, J. F., Balasubramanian, S., Eckert, R. L. and Rorke, E. A. 2004. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 279:12755.
9. Rezai-Zadeh, K., Shytle, D., Sun, N. et al. 2005. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 25:8807.
10. Ribaldo, P. D., Souza, D. S., Biswas, S. K., Block, K., Lopes de Faria, J. M. and Lopes de Faria, J. B. 2009. Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats. J. Nutr. 139:96.
11. Tachibana, H., Koga, K., Fujimura, Y. and Yamada, K. 2004. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 11:380.
12. Hand, P. H., Thor, A., Schlom, J., Rao, C. N. and Liotta, L. 1985. Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody. Cancer Res. 45:2713.
13. Adachi, S., Nagao, T., Ingolfsson, H. I. et al. 2007. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 67:6493.
14. Hashimoto, M., Ayada, T., Kinjyo, I. et al. 2009. Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. Cancer Sci. 100:730.
15. Naka, T., Narazaki, M., Hirata, M. et al. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924.
16. Yoshimura, A., Naka, T. and Kubo, M. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7:454.
17. Nakagawa, R., Naka, T., Tsutsui, H. et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677.
18. Kimura, A., Naka, T., Muta, T. et al. 2005. Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc. Natl Acad. Sci. USA 102:17089.
19. Sakamoto, H., Kinjyo, I. and Yoshimura, A. 2000. The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons. Leuk. Lymphoma 38:49.
20. Elbling, L., Weiss, R. M., Teufelhofer, O. et al. 2005. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J. 19:807.
21. Hou, Z., Sang, S., You, H. et al. 2005. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 65:8049.
22. Yang, C. S., Lee, M. J. and Chen, L. 1999. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiol. Biomarkers Prev. 8:83.
23. Ullmann, U., Haller, J., Decourt, J. P. et al. 2003. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 31:88.
24. Nagle, D. G., Ferreira, D. and Zhou, Y. D. 2006. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 67:1849.
25. Townsend, P. A., Scarabelli, T. M., Pasini, E. et al. 2004. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 18:1621.
26. Sporri, B., Kovanen, P. E., Sasaki, A., Yoshimura, A. and Leonard, W. J. 2001. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood 97:221.
27. Simon, A. R., Rai, U., Fanburg, B. L. and Cochran, B. H. 1998. Activation of the JAK-STAT pathway by reactive oxygen species. Am. J. Physiol. 275:1640.
28. Carballo, M., Conde, M., El Bekay, R. et al. 1999. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J. Biol. Chem. 274:17580.
29. Madamanchi, N. R., Moon, S. K., Hakim, Z. S. et al. 2005. Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms. Arterioscler. Thromb. Vasc. Biol. 25:950.
30. Schieffer, B., Luchtefeld, M., Braun, S., Hilfiker, A., Hilfiker-Kleiner, D. and Drexler, H. 2000. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ. Res. 87:1195.
31. Sang, S., Lambert, J. D., Hong, J. et al. 2005. Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice. Chem. Res. Toxicol. 18:1762.
32. Palacios-Callender, M., Quintero, M., Hollis, V. S., Springett, R. J. and Moncada, S. 2004. Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc. Natl Acad. Sci. USA 101:7630.
33. Yang, F., de Villiers, W. J., McClain, C. J. and Varilek, G. W. 1998. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr. 128:2334.